Submit Deal

Guido Oelkers

President and CEO at SWEDISH ORPHAN BIOVITRUM AB (SOBI)

Manager

Deal Bio

Total Deals4

Valued Deals4

Total Value£8,310M

Avg. Deal Size£2,077M

Market Context

Expertise (4)

Key Relationships

Sort

Switzerland

Pharmaceuticals

AcquisitionPrivateMajority

target

Novimmune (emapalumab And Related Assets)

bidder

Swedish Orphan Biovitrum (sobi)

£409m

31 dealmakers

United States

Pharmaceuticals

PublicMajorityMergerAcquisition

target

Dova Pharmaceuticals

bidder

Swedish Orphan Biovitrum (sobi)

£744m

26 dealmakers

Sweden

Biotechnology

MajorityAcquisitionTender OfferCross BorderPrivate EquityPublic

target

Swedish Orphan Biovitrum (sobi)

bidder

Advent International Corporation

£5,809m

39 dealmakers

United States

Pharmaceuticals

Tender OfferCross BorderMajorityPublicAcquisitionPrivate Equity

target

Cti Biopharma

bidder

Swedish Orphan Biovitrum (sobi)

£1,347m

76 dealmakers

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.